361 related articles for article (PubMed ID: 16096013)
1. Sleeping beauty transposon-mediated gene therapy for prolonged expression.
Hackett PB; Ekker SC; Largaespada DA; McIvor RS
Adv Genet; 2005; 54():189-232. PubMed ID: 16096013
[TBL] [Abstract][Full Text] [Related]
2. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates.
Izsvák Z; Ivics Z; Plasterk RH
J Mol Biol; 2000 Sep; 302(1):93-102. PubMed ID: 10964563
[TBL] [Abstract][Full Text] [Related]
3. Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.
Ohlfest JR; Lobitz PD; Perkinson SG; Largaespada DA
Mol Ther; 2004 Aug; 10(2):260-8. PubMed ID: 15294173
[TBL] [Abstract][Full Text] [Related]
4. Excision of Sleeping Beauty transposons: parameters and applications to gene therapy.
Liu G; Aronovich EL; Cui Z; Whitley CB; Hackett PB
J Gene Med; 2004 May; 6(5):574-83. PubMed ID: 15133768
[TBL] [Abstract][Full Text] [Related]
5. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
[TBL] [Abstract][Full Text] [Related]
6. Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors.
Moldt B; Yant SR; Andersen PR; Kay MA; Mikkelsen JG
Hum Gene Ther; 2007 Dec; 18(12):1193-204. PubMed ID: 17988194
[TBL] [Abstract][Full Text] [Related]
7. Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses.
Aronovich EL; Bell JB; Belur LR; Gunther R; Koniar B; Erickson DC; Schachern PA; Matise I; McIvor RS; Whitley CB; Hackett PB
J Gene Med; 2007 May; 9(5):403-15. PubMed ID: 17407189
[TBL] [Abstract][Full Text] [Related]
8. Sleeping Beauty Transposition.
Ivics Z; Izsvák Z
Microbiol Spectr; 2015 Apr; 3(2):MDNA3-0042-2014. PubMed ID: 26104705
[TBL] [Abstract][Full Text] [Related]
9. Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I.
Wilber A; Wangensteen KJ; Chen Y; Zhuo L; Frandsen JL; Bell JB; Chen ZJ; Ekker SC; McIvor RS; Wang X
Mol Ther; 2007 Jul; 15(7):1280-7. PubMed ID: 17440442
[TBL] [Abstract][Full Text] [Related]
10. Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
Sumiyoshi T; Holt NG; Hollis RP; Ge S; Cannon PM; Crooks GM; Kohn DB
Hum Gene Ther; 2009 Dec; 20(12):1607-26. PubMed ID: 19689196
[TBL] [Abstract][Full Text] [Related]
11. Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.
Huang X; Wilber AC; Bao L; Tuong D; Tolar J; Orchard PJ; Levine BL; June CH; McIvor RS; Blazar BR; Zhou X
Blood; 2006 Jan; 107(2):483-91. PubMed ID: 16189271
[TBL] [Abstract][Full Text] [Related]
12. Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system.
Belur LR; Frandsen JL; Dupuy AJ; Ingbar DH; Largaespada DA; Hackett PB; Scott McIvor R
Mol Ther; 2003 Sep; 8(3):501-7. PubMed ID: 12946324
[TBL] [Abstract][Full Text] [Related]
13. Liver-directed gene therapy using the sleeping beauty transposon system.
Belur LR; McIvor RS; Wilber A
Methods Mol Biol; 2008; 434():267-76. PubMed ID: 18470650
[TBL] [Abstract][Full Text] [Related]
14. Awakening gene therapy with Sleeping Beauty transposons.
Essner JJ; McIvor RS; Hackett PB
Curr Opin Pharmacol; 2005 Oct; 5(5):513-9. PubMed ID: 16084771
[TBL] [Abstract][Full Text] [Related]
15. Duration of expression and activity of Sleeping Beauty transposase in mouse liver following hydrodynamic DNA delivery.
Bell JB; Aronovich EL; Schreifels JM; Beadnell TC; Hackett PB
Mol Ther; 2010 Oct; 18(10):1796-802. PubMed ID: 20628359
[TBL] [Abstract][Full Text] [Related]
16. Genomic analysis of Sleeping Beauty transposon integration in human somatic cells.
Turchiano G; Latella MC; Gogol-Döring A; Cattoglio C; Mavilio F; Izsvák Z; Ivics Z; Recchia A
PLoS One; 2014; 9(11):e112712. PubMed ID: 25390293
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of in situ PCR-amplified Sleeping Beauty transposon genes to cancer cells with lipid-based nanoparticle-like protocells.
Ma K; Fu D; Yu D; Cui C; Wang L; Guo Z; Mao C
Biomaterials; 2017 Mar; 121():55-63. PubMed ID: 28081459
[TBL] [Abstract][Full Text] [Related]
18. The Sleeping Beauty transposon system: a non-viral vector for gene therapy.
Aronovich EL; McIvor RS; Hackett PB
Hum Mol Genet; 2011 Apr; 20(R1):R14-20. PubMed ID: 21459777
[TBL] [Abstract][Full Text] [Related]
19. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA
Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839
[TBL] [Abstract][Full Text] [Related]
20. Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors.
Izsvák Z; Chuah MK; Vandendriessche T; Ivics Z
Methods; 2009 Nov; 49(3):287-97. PubMed ID: 19615447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
